Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting
“At ASCO, we are reporting early clinical data for three [...]
“At ASCO, we are reporting early clinical data for three [...]
The company updated the Phase 1b efficacy and safety results [...]
Dr. Vibhor Gupta, Founder and Director at Pangaea, said: “We [...]
Omeros received approximately $126 million in cash at closing. In [...]